Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma

NCT00823459 is registered in ClinicalTrials.gov with Susan Chang as lead sponsor.

NCT NCT00823459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Lead sponsor
Susan Chang
Phase
Phase 2
Overall status
Completed
Start date
January 23, 2009
Completion date
November 13, 2017
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult diffuse astrocytoma, adult mixed glioma, adult oligodendroglioma, adult subependymal giant cell astrocytoma, recurrent adult brain neoplasm